Neuroprotection by remote ischemic conditioning in the setting of acute ischemic stroke: a preclinical two-centre study.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
09 10 2020
Historique:
received: 26 03 2020
accepted: 22 09 2020
entrez: 10 10 2020
pubmed: 11 10 2020
medline: 9 3 2021
Statut: epublish

Résumé

Reperfusion is the only existing strategy for patients with acute ischemic stroke, however it causes further brain damage itself. A feasible therapy targeting reperfusion injury is remote ischemic conditioning (RIC). This was a two-centre, randomized, blinded international study, using translational imaging endpoints, aimed to examine the neuroprotective effects of RIC in ischemic stroke model. 80 male rats underwent 90-min middle cerebral artery occlusion. RIC consisted of 4 × 5 min cycles of left hind limb ischemia. The primary endpoint was infarct size measured on T2-weighted MRI at 24 h, expressed as percentage of the area-at-risk. Secondary endpoints were: hemispheric space-modifying edema, infarct growth between per-occlusion and 24 h MRI, neurofunctional outcome measured by neuroscores. 47 rats were included in the analysis after applying pre-defined inclusion criteria. RIC significantly reduced infarct size (median, interquartile range: 19% [8%; 32%] vs control: 40% [17%; 59%], p = 0.028). This effect was still significant after adjustment for apparent diffusion coefficient lesion size in multivariate analysis. RIC also improved neuroscores (6 [3; 8] vs control: 9 [7; 11], p = 0.032). Other secondary endpoints were not statistically different between groups. We conclude that RIC in the setting of acute ischemic stroke in rats is safe, reduces infarct size and improves functional recovery.

Identifiants

pubmed: 33037284
doi: 10.1038/s41598-020-74046-4
pii: 10.1038/s41598-020-74046-4
pmc: PMC7547701
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

16874

Subventions

Organisme : Department of Health
ID : BRC233/CM/SD/101320
Pays : United Kingdom

Références

Stroke and transient ischaemic attack in over 16s: diagnosis and initial management—NICE guideline | RCP London. https://www.rcplondon.ac.uk/guidelines-policy/stroke-and-transient-ischaemic-attack-over-16s-diagnosis-and-initial-management-nice-guideline . (Accessed 29 November 2019).
Powers, W. J. et al. 2018 Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 49, e46–e110 (2018).
pubmed: 29367334 doi: 10.1161/STR.0000000000000158
Carvalho, A. et al. Mechanical thrombectomy in acute ischemic stroke: initial single-center experience and comparison with randomized controlled trials. J. Stroke Cerebrovasc. Dis. 26, 589–594 (2017).
pubmed: 28038899 doi: 10.1016/j.jstrokecerebrovasdis.2016.11.116
Goyal, M. et al. Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet (Lond. Engl.) 387, 1723–1731 (2016).
doi: 10.1016/S0140-6736(16)00163-X
Badhiwala, J. H. et al. Endovascular thrombectomy for acute ischemic stroke ameta-analysis. JAMA J. Am. Med. Assoc. 314, 1832–1843 (2015).
doi: 10.1001/jama.2015.13767
Yellon, D. M. & Hausenloy, D. J. Myocardial reperfusion injury. N. Engl. J. Med. 357, 1121–1135 (2007).
pubmed: 17855673 pmcid: 17855673 doi: 10.1056/NEJMra071667
Hausenloy, D. J. et al. Ischaemic conditioning and targeting reperfusion injury: a 30 year voyage of discovery. Basic Res. Cardiol. 111, 70 (2016).
pubmed: 27766474 pmcid: 5073120 doi: 10.1007/s00395-016-0588-8
Bell, R. M. et al. 9th Hatter Biannual Meeting: position document on ischaemia/reperfusion injury, conditioning and the ten commandments of cardioprotection. Basic Res. Cardiol. 111, 41 (2016).
pubmed: 27164905 pmcid: 4863033 doi: 10.1007/s00395-016-0558-1
Li, D., Shao, Z., Vanden Hoek, T. L. & Brorson, J. R. Reperfusion accelerates acute neuronal death induced by simulated ischemia. Exp. Neurol. 206, 280–287 (2007).
pubmed: 17599834 pmcid: 3648807 doi: 10.1016/j.expneurol.2007.05.017
Aronowski, J., Strong, R. & Grotta, J. C. Reperfusion injury: demonstration of brain damage produced by reperfusion after transient focal ischemia in rats. J. Cereb. Blood Flow Metab. 17, 1048–1056 (1997).
pubmed: 9346429 doi: 10.1097/00004647-199710000-00006
Pundik, S., Xu, K. & Sundararajan, S. Reperfusion brain injury: focus on cellular bioenergetics. Neurology 79, S44–S51 (2012).
pubmed: 23008411 doi: 10.1212/WNL.0b013e3182695a14
Dirnagl, U., Iadecola, C. & Moskowitz, M. A. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci. 22, 391–397 (1999).
pubmed: 10441299 doi: 10.1016/S0166-2236(99)01401-0
Bai, J. & Lyden, P. D. Revisiting cerebral postischemic reperfusion injury: new insights in understanding reperfusion failure, hemorrhage, and edema. Int. J. Stroke 10, 143–152 (2015).
pubmed: 25598025 doi: 10.1111/ijs.12434
Jung, J. E. et al. Reperfusion and neurovascular dysfunction in stroke: from basic mechanisms to potential strategies for neuroprotection. Mol. Neurobiol. 41, 172–179 (2010).
pubmed: 20157789 pmcid: 2877155 doi: 10.1007/s12035-010-8102-z
Savitz, S. I., Baron, J. C., Yenari, M. A., Sanossian, N. & Fisher, M. Reconsidering neuroprotection in the reperfusion era. Stroke 48, 3413–3419 (2017).
pubmed: 29146878 doi: 10.1161/STROKEAHA.117.017283
Pickard, J. M. J. et al. Remote ischemic conditioning: from experimental observation to clinical application: report from the 8th Biennial Hatter Cardiovascular Institute Workshop. Basic Res. Cardiol. 110, 453 (2015).
pubmed: 25449895 doi: 10.1007/s00395-014-0453-6
Hougaard, K. D. et al. Remote ischemic perconditioning as an adjunct therapy to thrombolysis in patients with acute ischemic stroke: a randomized trial. Stroke 45, 159–167 (2014).
pubmed: 24203849 doi: 10.1161/STROKEAHA.113.001346
Landman, T. R. J., Schoon, Y., Warlé, M. C., de Leeuw, F.-E. & Thijssen, D. H. J. Remote ischemic conditioning as an additional treatment for acute ischemic stroke. Stroke 50, 1934–1939 (2019).
pubmed: 31154944 doi: 10.1161/STROKEAHA.119.025494
Pico, F. et al. A multicenter, randomized trial on neuroprotection with remote ischemic per-conditioning during acute ischemic stroke: the remote ischemic conditioning in acute brain infarction study protocol. Int. J. Stroke 11, 938–943 (2016).
pubmed: 27412192 doi: 10.1177/1747493016660098
Chen, G., Thakkar, M., Robinson, C. & Doré, S. Limb remote ischemic conditioning: mechanisms, anesthetics, and the potential for expanding therapeutic options. Front. Neurol. 9, 40 (2018).
pubmed: 29467715 pmcid: 5808199 doi: 10.3389/fneur.2018.00040
Weir, P., Maguire, R., O’Sullivan, S. E. & England, T. J. A meta-analysis of remote ischaemic conditioning in experimental stroke. J. Cereb. Blood Flow Metab. https://doi.org/10.1177/0271678x20924077 (2020).
doi: 10.1177/0271678x20924077 pubmed: 32538284
Fisher, M. et al. Update of the stroke therapy academic industry roundtable preclinical recommendations. Stroke 40, 2244–2250 (2009).
pubmed: 19246690 pmcid: 2888275 doi: 10.1161/STROKEAHA.108.541128
Lapchak, P. A. & Zhang, J. H. Translational stroke research guideline projections: the 20/20 standards. Transl. Stroke Res. 9, 9–12 (2018).
pubmed: 28386732 doi: 10.1007/s12975-017-0534-6
Neuhaus, A. A., Couch, Y., Hadley, G. & Buchan, A. M. Neuroprotection in stroke: the importance of collaboration and reproducibility. Brain 140, 2079–2092 (2017).
pubmed: 28641383 doi: 10.1093/brain/awx126
Dirnagl, U. et al. A concerted appeal for international cooperation in preclinical stroke research. Stroke 44, 1754–1760 (2013).
pubmed: 23598526 pmcid: 3933930 doi: 10.1161/STROKEAHA.113.000734
Kilkenny, C. et al. Animal research: reporting in vivo experiments: the ARRIVE guidelines. Br. J. Pharmacol. 160, 1577–1579 (2010).
pubmed: 20649561 pmcid: 2936830 doi: 10.1111/j.1476-5381.2010.00872.x
Cho, T.-H. et al. Pre- and post-treatment with cyclosporine a in a rat model of transient focal cerebral ischaemia with multimodal MRI screening. Int. J. Stroke 8, 669–674 (2013).
pubmed: 22882746 doi: 10.1111/j.1747-4949.2012.00849.x
Longa, E. Z., Weinstein, P. R., Carlson, S. & Cummins, R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20, 84–91 (1989).
pubmed: 2643202 doi: 10.1161/01.STR.20.1.84
Spratt, N. J. et al. Modification of the method of thread manufacture improves stroke induction rate and reduces mortality after thread-occlusion of the middle cerebral artery in young or aged rats. J. Neurosci. Methods 155, 285–290 (2006).
pubmed: 16513179 doi: 10.1016/j.jneumeth.2006.01.020
Hahn, C. D., Manlhiot, C., Schmidt, M. R., Nielsen, T. T. & Redington, A. N. Remote ischemic per-conditioning: a novel therapy for acute stroke?. Stroke 42, 2960–2962 (2011).
pubmed: 21836089 doi: 10.1161/STROKEAHA.111.622340
Brandli, A. Remote limb ischemic preconditioning: a neuroprotective technique in rodents. J. Vis. Exp https://doi.org/10.3791/52213 (2015).
doi: 10.3791/52213 pubmed: 26131649 pmcid: 4545155
Bederson, J. B. et al. Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke 17, 472–476 (1986).
pubmed: 3715945 doi: 10.1161/01.STR.17.3.472
Pérez-Asensio, F. J. et al. Inhibition of iNOS activity by 1400W decreases glutamate release and ameliorates stroke outcome after experimental ischemia. Neurobiol. Dis. 18, 375–384 (2005).
pubmed: 15686966 doi: 10.1016/j.nbd.2004.10.018
van der Zijden, J. P. et al. Manganese-enhanced MRI of brain plasticity in relation to functional recovery after experimental stroke. J. Cereb. Blood Flow Metab. 28, 832–840 (2008).
pubmed: 17987047 doi: 10.1038/sj.jcbfm.9600576
Chauveau, F. et al. Does acute behavioral testing reflect successful ischemia in rats with transient middle cerebral artery occlusion?. Int. J. Stroke 7, 465–472 (2012).
pubmed: 22151768 doi: 10.1111/j.1747-4949.2011.00710.x
MATLAB:2013, version 8.1 (R2013a), The MathWorks Inc., Natick, Massachusetts.
Chauveau, F. et al. Brain-targeting form of docosahexaenoic acid for experimental stroke treatment: MRI evaluation and anti-oxidant impact. Curr. Neurovasc. Res. 8, 95–102 (2011).
pubmed: 21443458 doi: 10.2174/156720211795495349
Gerriets, T. et al. Noninvasive quantification of brain edema and the space-occupying effect in rat stroke models using magnetic resonance imaging. Stroke 35, 566–571 (2004).
pubmed: 14739415 doi: 10.1161/01.STR.0000113692.38574.57
Koch, S. et al. Atlas registration for edema-corrected MRI lesion volume in mouse stroke models. J. Cereb. Blood Flow Metab. 39, 313–323 (2019).
pubmed: 28829217 doi: 10.1177/0271678X17726635
R: A language and environment for statistical computing, R Core Team, R Foundation for Statistical Computing, Vienna, Austria, 2019, https://www.R-project.org/ .
Leslie-Mazwi, T. M. et al. DEFUSE 3 non-DAWN patients: a closer look at late window thrombectomy selection. Stroke 50, 618–625 (2019).
pubmed: 30727856 pmcid: 6768068 doi: 10.1161/STROKEAHA.118.023310
Llovera, G. et al. Results of a preclinical randomized controlled multicenter trial (pRCT): anti-CD49d treatment for acute brain ischemia. Sci. Transl. Med. 7, 299ra121 (2015).
pubmed: 26246166 doi: 10.1126/scitranslmed.aaa9853
Voelkl, B., Vogt, L., Sena, E. S. & Würbel, H. Reproducibility of preclinical animal research improves with heterogeneity of study samples. PLoS Biol. 16, e2003693 (2018).
pubmed: 29470495 pmcid: 5823461 doi: 10.1371/journal.pbio.2003693
Bohl, S. et al. Refined approach for quantification of in vivo ischemia-reperfusion injury in the mouse heart. Am. J. Physiol. Circ. Physiol. 297, H2054–H2058 (2009).
doi: 10.1152/ajpheart.00836.2009
Nogueira, R. G. et al. Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. N. Engl. J. Med. 378, 11–21 (2018).
pubmed: 29129157 doi: 10.1056/NEJMoa1706442
Bardutzky, J. et al. Characterizing tissue fate after transient cerebral ischemia of varying duration using quantitative diffusion and perfusion imaging. Stroke 38, 1336–1344 (2007).
pubmed: 17322082 pmcid: 2900771 doi: 10.1161/01.STR.0000259636.26950.3b
Wheeler, H. M. et al. The growth rate of early DWI lesions is highly variable and associated with penumbral salvage and clinical outcomes following endovascular reperfusion. Int. J. Stroke 10, 723–729 (2015).
pubmed: 25580662 pmcid: 4478123 doi: 10.1111/ijs.12436
Li, F., Silva, M. D., Sotak, C. H. & Fisher, M. Temporal evolution of ischemic injury evaluated with diffusion-, perfusion-, and T2-weighted MRI. Neurology 54, 689–696 (2000).
pubmed: 10680805 doi: 10.1212/WNL.54.3.689
Basalay, M. V., Davidson, S. M. & Yellon, D. M. Neuroprotection in rats following ischaemia-reperfusion injury by GLP-1 analogues: liraglutide and semaglutide. Cardiovasc. Drugs Ther. 33, 661–667 (2019).
pubmed: 31721014 pmcid: 6994526 doi: 10.1007/s10557-019-06915-8
Campbell, B. C. V. et al. Penumbral imaging and functional outcome in patients with anterior circulation ischaemic stroke treated with endovascular thrombectomy versus medical therapy: a meta-analysis of individual patient-level data. Lancet Neurol. 18, 46–55 (2019).
pubmed: 30413385 doi: 10.1016/S1474-4422(18)30314-4
Cuccione, E. et al. Multi-site laser Doppler flowmetry for assessing collateral flow in experimental ischemic stroke: validation of outcome prediction with acute MRI. J. Cereb. Blood Flow Metab. 37, 2159–2170 (2017).
pubmed: 27466372 doi: 10.1177/0271678X16661567
Heusch, G. Cardioprotection research must leave its comfort zone. Eur. Heart J. 39, 3393–3395 (2018).
pubmed: 29722801 doi: 10.1093/eurheartj/ehy253
Heusch, G. 25 years of remote ischemic conditioning: from laboratory curiosity to clinical outcome. Basic Res. Cardiol. 113, 15 (2018).
pubmed: 29516255 doi: 10.1007/s00395-018-0673-2
Hausenloy, D. J. & Bøtker, H. E. Why did remote ischaemic conditioning not improve clinical outcomes in acute myocardial infarction in the CONDI-2/ERIC-PPCI trial?. Cardiovasc. Res. 115, e161–e163 (2019).
pubmed: 31621833
Ibanez, B. et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur. Heart J. 39, 119–177 (2018).
pubmed: 28886621 doi: 10.1093/eurheartj/ehx393
Ibanez, B. et al. Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the effect of metoprolol in cardioprotection during an acute myocardial infarction (METOCARD-CNIC) trial. Circulation 128, 1495–1503 (2013).
pubmed: 24002794 doi: 10.1161/CIRCULATIONAHA.113.003653
Yang, X.-M. et al. Platelet P2Y
pubmed: 23233653 doi: 10.1177/1074248412467692
Yang, X.-M., Cui, L., Alhammouri, A., Downey, J. M. & Cohen, M. V. Triple therapy greatly increases myocardial salvage during ischemia/reperfusion in the in situ rat heart. Cardiovasc. Drugs Ther. 27, 403–412 (2013).
pubmed: 23832692 doi: 10.1007/s10557-013-6474-9
Vilahur, G. et al. Protective effects of ticagrelor on myocardial injury after infarction. Circulation 134, 1708–1719 (2016).
pubmed: 27789556 doi: 10.1161/CIRCULATIONAHA.116.024014
Khan, J. N. et al. Infarct size following treatment with second- versus third-generation P2Y12 antagonists in patients with multivessel coronary disease at ST-segment elevation myocardial infarction in the CvLPRIT study. J. Am. Heart Assoc. 5, e003403 (2016).
pubmed: 27247336 pmcid: 4937278 doi: 10.1161/JAHA.116.003403
Hausenloy, D. J. et al. Effect of remote ischaemic conditioning on clinical outcomes in patients with acute myocardial infarction (CONDI-2/ERIC-PPCI): a single-blind randomised controlled trial. Lancet 394, 1415–1424 (2019).
pubmed: 31500849 pmcid: 6891239 doi: 10.1016/S0140-6736(19)32039-2
Basalay, M. V., Davidson, S. M., Gourine, A. V. & Yellon, D. M. Neural mechanisms in remote ischaemic conditioning in the heart and brain: mechanistic and translational aspects. Basic Res. Cardiol. 113, 25 (2018).
pubmed: 29858664 pmcid: 5984640 doi: 10.1007/s00395-018-0684-z

Auteurs

Maryna V Basalay (MV)

The Hatter Cardiovascular Institute, University College London, 67 Chenies Mews, London, WC1E 6HX, UK.

Marlene Wiart (M)

Univ Lyon, CarMeN Laboratory, INSERM 1060, INRA U1397, INSA Lyon, Université Claude Bernard Lyon 1, Oullins, France.

Fabien Chauveau (F)

Univ Lyon, Lyon Neuroscience Research Center, CNRS UMR5292, INSERM U1028, Université Claude Bernard Lyon 1, Lyon, France.

Chloe Dumot (C)

Univ Lyon, CarMeN Laboratory, INSERM 1060, INRA U1397, INSA Lyon, Université Claude Bernard Lyon 1, Oullins, France.

Christelle Leon (C)

Univ Lyon, CarMeN Laboratory, INSERM 1060, INRA U1397, INSA Lyon, Université Claude Bernard Lyon 1, Oullins, France.

Camille Amaz (C)

Clinical Investigation Center, CIC 1407, HCL, Louis Pradel Hospital, Lyon, France.

Radu Bolbos (R)

CERMEP-Imagerie du Vivant, Lyon, France.

Diana Cash (D)

Department of Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience, King's College London, James Black Centre, 125 Coldharbour Lane, London, SE5 9NU, UK.

Eugene Kim (E)

Department of Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience, King's College London, James Black Centre, 125 Coldharbour Lane, London, SE5 9NU, UK.

Laura Mechtouff (L)

Univ Lyon, CREATIS, CNRS UMR 5220, INSERM U1206, INSA-Lyon, Université Claude Bernard Lyon 1, Lyon, France.
Stroke Department, Hospices Civils de Lyon, Lyon, France.

Tae-Hee Cho (TH)

Univ Lyon, CREATIS, CNRS UMR 5220, INSERM U1206, INSA-Lyon, Université Claude Bernard Lyon 1, Lyon, France.
Stroke Department, Hospices Civils de Lyon, Lyon, France.

Norbert Nighoghossian (N)

Univ Lyon, CREATIS, CNRS UMR 5220, INSERM U1206, INSA-Lyon, Université Claude Bernard Lyon 1, Lyon, France.
Stroke Department, Hospices Civils de Lyon, Lyon, France.

Sean M Davidson (SM)

The Hatter Cardiovascular Institute, University College London, 67 Chenies Mews, London, WC1E 6HX, UK.

Michel Ovize (M)

Univ Lyon, CarMeN Laboratory, INSERM 1060, INRA U1397, INSA Lyon, Université Claude Bernard Lyon 1, Oullins, France.

Derek M Yellon (DM)

The Hatter Cardiovascular Institute, University College London, 67 Chenies Mews, London, WC1E 6HX, UK. d.yellon@ucl.ac.uk.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH